Development of phage resistance in clinical Escherichia coli and Klebsiella pneumoniae isolates
Antimicrobial resistance (AMR) is an escalating global health threat, attributable to the diminishing availability of efficient antibiotics against bacterial infections. Phage therapy is considered an alternative therapeutic solution to treat resistant infections. In phage therapy, the bacteria are...
| Päätekijä: | |
|---|---|
| Muut tekijät: | , , , , , |
| Aineistotyyppi: | Pro gradu |
| Kieli: | eng |
| Julkaistu: |
2024
|
| Aiheet: | |
| Linkit: | https://jyx.jyu.fi/handle/123456789/94585 |